Literature DB >> 32257040

Phosphaturic Mesenchymal Tumors from Head to Toe: Imaging Findings and Role of the Radiologist in Diagnosing Tumor-Induced Osteomalacia.

Ameya S Kawthalkar1, Amit K Janu2, Mrunmayee S Deshpande3, Kunal B Gala2, Ashish Gulia4, Ajay Puri4.   

Abstract

BACKGROUND: This study aimed at evaluating the imaging findings of phosphaturic mesenchymal tumors and tumor-induced osteomalacia and assess the clinical and biochemical profiles of patients with tumor-induced osteomalacia.
MATERIALS AND METHODS: Imaging findings in six patients with tumor-induced osteomalacia and histopathologically proven phosphaturic mesenchymal tumors were evaluated. Clinical and biochemical profiles of these patients were also assessed.
RESULTS: Along with having a characteristic biochemical profile, patients with phosphaturic mesenchymal tumors also have certain imaging findings which can aid in the diagnosis such as increased uptake on DOTA PET-CT and homogeneous post-contrast enhancement on CT and MRI.
CONCLUSION: Patients with tumor-induced osteomalacia have characteristic symptoms, imaging and biochemical profiles. For radiologists, raising the suspicion of a phosphaturic mesenchymal tumor in patients with refractory hypophosphatemic osteomalacia as well as localizing the tumor on imaging is crucial, as complete excision of the tumor leads to resolution of the osteomalacia and the patient's clinical symptoms. © Indian Orthopaedics Association 2020.

Entities:  

Keywords:  Bone tumors; DOTA PET; Nuclear medicine; Phosphaturic mesenchymal tumor; Radiology; Tumor-induced osteomalacia

Year:  2020        PMID: 32257040      PMCID: PMC7096593          DOI: 10.1007/s43465-019-00005-5

Source DB:  PubMed          Journal:  Indian J Orthop        ISSN: 0019-5413            Impact factor:   1.251


  13 in total

1.  Ga68-DOTA Peptide PET/CT to Detect Occult Mesenchymal Tumor-Inducing Osteomalacia: A Case Series of Three Patients.

Authors:  Chi Long Ho
Journal:  Nucl Med Mol Imaging       Date:  2015-03-25

2.  Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spectrum.

Authors:  Abbas Agaimy; Michael Michal; Simion Chiosea; Fredrik Petersson; Ladislav Hadravsky; Glenn Kristiansen; Raymund E Horch; Jan Schmolders; Arndt Hartmann; Florian Haller; Michal Michal
Journal:  Am J Surg Pathol       Date:  2017-10       Impact factor: 6.394

Review 3.  Hypophosphatemia: an update on its etiology and treatment.

Authors:  André Gaasbeek; A Edo Meinders
Journal:  Am J Med       Date:  2005-10       Impact factor: 4.965

4.  Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.

Authors:  F Tartaglia; S Minisola; M Sgueglia; S Blasi; D Brunelli; E Degli Effetti; A Maturo; A Cola; F Custureri; F P Campana
Journal:  G Chir       Date:  2006 Jan-Feb

5.  The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?

Authors:  Cameron K Ledford; Nicole A Zelenski; Diana M Cardona; Brian E Brigman; William C Eward
Journal:  Clin Orthop Relat Res       Date:  2013-07-19       Impact factor: 4.176

6.  Phosphaturic mesenchymal tumour mixed connective tissue variant: report of three cases with unusual histological findings.

Authors:  David A Shustik; David Ce Ng; Kesavan Sittampalam
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

7.  Sinonasal Phosphaturic Mesenchymal Tumor: A Rare and Misinterpreted Entity.

Authors:  Demetri Arnaoutakis; Iman Naseri
Journal:  J Neurol Surg Rep       Date:  2015-08-21

8.  Phosphaturic mesenchymal tumor (PMT): exceptionally rare disease, yet crucial not to miss.

Authors:  Amir Ghorbani-Aghbolaghi; Morgan Angus Darrow; Tao Wang
Journal:  Autops Case Rep       Date:  2017-09-30

9.  Malignant phosphaturic mesenchymal tumor with pulmonary metastasis: A case report.

Authors:  Shui Qiu; Li-Li Cao; Yue Qiu; Ping Yan; Zi-Xuan Li; Jiang Du; Li-Mei Sun; Qing-Fu Zhang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

10.  CT and MR imaging features in phosphaturic mesenchymal tumor-mixed connective tissue: A case report.

Authors:  Zhenshan Shi; Yiqiong Deng; Xiumei Li; Yueming Li; Dairong Cao; Vikash Sahadeo Coossa
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

View more
  3 in total

1.  Phosphaturic Mesenchymal Tumor.

Authors:  J C Benson; J A Trejo-Lopez; A M Nassiri; K Eschbacher; M J Link; C L Driscoll; R D Tiegs; J Sfeir; D R DeLone
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-19       Impact factor: 4.966

2.  Tumor-induced osteomalacia characterized by "painful knee joint with difficulty in moving": a case report.

Authors:  Lan Jiang; Qing-Qing Tan; Chen-Lin Gao; Ling Xu; Jian-Hua Zhu; Pi-Jun Yan; Ying Miao; Qin Wan; Yong Xu
Journal:  BMC Endocr Disord       Date:  2022-07-08       Impact factor: 3.263

Review 3.  Phosphaturic mesenchymal tumors: radiological aspects and suggested imaging pathway.

Authors:  Mohsin A M Hussein; Francesco Pio Cafarelli; Maria Teresa Paparella; Winston J Rennie; Giuseppe Guglielmi
Journal:  Radiol Med       Date:  2021-08-28       Impact factor: 3.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.